Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Qiagen NV (QGEN)
NYSE:QGEN
QGEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$39.03 - $47.93
Previous CloseN/A
Volume260.87K
Average Volume (3M)1.01M
Market Cap
$10.12B
Enterprise Value$10.65B
Total Cash (Recent Filing)$533.38M
Total Debt (Recent Filing)$1.07B
Price to Earnings (P/E)113.0
Beta0.69
Next Earnings
Feb 05, 2025EPS Estimate
0.6Last Dividend Ex-Date
Jan 30, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)0.40
Shares Outstanding221,847,000
10 Day Avg. Volume1,456,770
30 Day Avg. Volume1,010,876
Standard Deviation0.06
R-Squared0.10
Alpha0.00177
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.30
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.63
Enterprise Value/Ebitda31.14
Forecast
1Y Price Target
$50.89Price Target Upside12.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
Capital Allocation StrategyThe intent to return ~$300mn in shareholder capital is seen as a disciplined and shareholder-friendly capital allocation strategy by QIAGEN.
Financial PositionQGEN has a net debt-EBITDA of approximately 0.0x and projected free cash flow of more than $500M per year over the next three years, indicating a strong financial position.
Operational PerformanceThe company reported encouraging 3Q results with revenue and EPS ahead of the analyst's model, primarily driven by strength in diagnostic solutions.
Bears Say
CompetitionChannel checks suggest the QIAStat-Dx is seeing signs of competition in the US from labs consolidating their multiplex testing toward the market leader and shifting some volume to a newer/lower-cost competitor.
EarningsFactoring in lost interest income could result in a relative 1% cut to EPS as a result of the $300M deployment.
Product DemandQiagen's TB test (QFT) will see its third year of growth deceleration, signalling a normalization of testing demand.
---
Ownership Overview
0.44% Insiders
21.00% Mutual Funds
0.38% Other Institutional Investors
63.98% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QGEN FAQ
What was Qiagen NV’s price range in the past 12 months?
Qiagen NV lowest stock price was $39.03 and its highest was $47.93 in the past 12 months.
What is Qiagen NV’s market cap?
Qiagen NV’s market cap is $10.12B.
When is Qiagen NV’s upcoming earnings report date?
Qiagen NV’s upcoming earnings report date is Feb 05, 2025 which is in 6 days.
How were Qiagen NV’s earnings last quarter?
Qiagen NV released its earnings results on Nov 06, 2024. The company reported $0.586 earnings per share for the quarter, beating the consensus estimate of $0.559 by $0.027.
Is Qiagen NV overvalued?
According to Wall Street analysts Qiagen NV’s price is currently Undervalued.
Does Qiagen NV pay dividends?
Qiagen NV pays a Notavailable dividend of $1.279 which represents an annual dividend yield of N/A. See more information on Qiagen NV dividends here
What is Qiagen NV’s EPS estimate?
Qiagen NV’s EPS estimate is 0.6.
How many shares outstanding does Qiagen NV have?
Qiagen NV has 221,847,000 shares outstanding.
What happened to Qiagen NV’s price movement after its last earnings report?
Qiagen NV reported an EPS of $0.586 in its last earnings report, beating expectations of $0.559. Following the earnings report the stock price went up 0.638%.
Which hedge fund is a major shareholder of Qiagen NV?
Currently, no hedge funds are holding shares in QGEN
---
Qiagen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$50.89 (12.74% Upside)
$50.89 (12.74% Upside)
Blogger Sentiment
Bullish
QGEN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 247.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 10.6%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.00%
12-Months-Change
Fundamentals
Return on Equity
2.63%
Trailing 12-Months
Asset Growth
6.15%
Trailing 12-Months
Company Description
Qiagen NV
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
---
QGEN Company Deck
---
QGEN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong sales, earnings, and profitability improvements, despite cautious instrument spending and challenges in China. The company is on track with strategic growth initiatives and has increased its earnings outlook.Read More>---
QGEN Stock 12 Month Forecast
Average Price Target
$50.89
▲(12.74% Upside)
Technical Analysis
Best Analysts Covering QGEN
1 Year
1 Year Success Rate
7/11 ratings generated profit
1 Year Average Return
+2.68%
reiterated a buy rating 8 months ago
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +2.68% per trade.
---